Skip to content

Company information lookup


Developer of innovative treatments for cancer and diseases of the central nervous system.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BNO 0.545 0.93% 0.540 0.550 0.535 0.545 0.530 25,619


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BNO
Official Listing Date 21 December, 1999
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address 31 Dalgleish Street, THEBARTON, SA, AUSTRALIA, 5031
Head Office Telephone 08 8354 6100
Head Office Fax 08 8354 6199
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Graeme Kaufman (Chairman)
Dr Deborah Rathjen (Managing Director, CEO)
Dr Errol De Souza (Non Exec. Director)
Dr Jonathan Lim (Non Exec. Director)
Mr Trevor Tappenden (Non Exec. Director)
Ms Melanie Young (CFO)
Company Secretary Ms Melanie Young
Principal Activities Developer of innovative treatments for cancer and diseases of the central nervous system.


How are company announcements published on

Date Price
Headline Pages PDF
31/10/2014 asterix Appendix 4C - quarterly 3 PDF
16/10/2014   Appendix 3B 12 PDF
14/10/2014 asterix BNC105 Data In International Peer-Reviewed Cancer Journal 2 PDF
10/10/2014   Notice of Annual General Meeting/Proxy Form 19 PDF
10/10/2014   Bionomics Annual Report 2014 88 PDF
29/09/2014   Correction - BNC105 Phase II Trial Biomarker Data 3 PDF
29/09/2014 asterix BNO Presents BNC105 Phase II Trial Biomarker Data 3 PDF
23/09/2014   Bionomics Investor Presentation 22 PDF
23/09/2014 asterix Bionomics Acquires Prestwick Chemical 2 PDF
05/09/2014 asterix Bionomics Receives $7.5M 2014 R&D Tax Incentive 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
30 Oct 2014 0.540 0% 0.555 0.525 80,729
29 Oct 2014 0.540 0% 0.545 0.540 6,556
28 Oct 2014 0.540 -2.7% 0.555 0.535 99,795
27 Oct 2014 0.555 -4.31% 0.575 0.550 225,333
24 Oct 2014 0.580 1.75% 0.585 0.560 78,101

* Volume of shares shown represents only those shares traded on ASX.

BIONOMICS LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security BNO. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BNO

Warrants & Structured Products

No warrants & Structured Products are available over the security BNO